WDNA holdings

All 81 positions of WisdomTree BioRevolution Fund.

Download CSV

Positions

Top 10 weight

30.7%

Effective holdings

50.7

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

20.8%

Asset mix

Equity99.9%
Cash0.1%

Sectors

84% of stocks classified

Health Care70.9%
Technology7.2%
Consumer Staples4.2%
Materials1.2%

Countries

United States79.1%
Switzerland4.6%
Germany3.1%
United Kingdom2.6%
Netherlands2.4%
Cayman Islands2.1%
Denmark1.8%
Bermuda1.7%
British Virgin Islands1.4%
Belgium0.6%
Australia0.5%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	TWSTTwist Bioscience Corporation Common Stock	Equity	5.95%	$159K	1,548	US
2	MRNAModerna, Inc. Common Stock	Equity	4.14%	$111K	1,584	US
3	LLYEli Lilly & Co.	Equity	4.08%	$109K	91	US
4	JNJJohnson & Johnson	Equity	2.97%	$79K	313	US
5	UTHRUnited Therapeutics Corp	Equity	2.45%	$66K	121	US
6	NTRANatera, Inc. Common Stock	Equity	2.32%	$62K	229	US
7	TEMTempus AI, Inc. Class A Common Stock	Equity	2.28%	$61K	1,055	US
8	IMNMImmunome, Inc.	Equity	2.26%	$60K	2,850	US
9	GPCRStructure Therapeutics Inc. American Depositary Shares	Equity	2.11%	$57K	1,055	KY
10	STOKStoke Therapeutics, Inc. Common Stock	Equity	2.09%	$56K	1,712	US
11	BEAMBeam Therapeutics Inc. Common Stock	Equity	2.09%	$56K	1,628	US
12	CTVACorteva, Inc. Common Stock	Equity	1.99%	$53K	629	US
13	KRYSKrystal Biotech, Inc. Common Stock	Equity	1.96%	$52K	141	US
14	DARDARLING INGREDIENTS INC.	Equity	1.94%	$52K	949	US
15	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	1.86%	$50K	627	US
16	ASTRAZENECA PLC	Equity	1.83%	$49K	258	GB
17	TXG10x Genomics, Inc. Class A Common Stock	Equity	1.81%	$48K	1,264	US
18	CRISPR THERAPEUTICS AG	Equity	1.77%	$47K	868	CH
19	ROIVANT SCIENCES LTD	Equity	1.73%	$46K	1,310	BM
20	ABSIAbsci Corporation Common Stock	Equity	1.71%	$46K	3,939	US
21	RVMDRevolution Medicines, Inc. Common Stock	Equity	1.69%	$45K	241	US
22	AGIOAgios Pharmaceuticals, Inc.	Equity	1.57%	$42K	1,134	US
23	AMGNAmgen Inc	Equity	1.54%	$41K	114	US
24	BAYER AG	Equity	1.53%	$41K	741	DE
25	TMOThermo Fisher Scientific, Inc.	Equity	1.52%	$41K	81	US
26	GILDGilead Sciences Inc	Equity	1.51%	$40K	320	US
27	BUNGE GLOBAL SA	Equity	1.51%	$40K	378	CH
28	ARWRArrowhead Research Corporation	Equity	1.47%	$39K	484	US
29	VCYTVeracyte, Inc.	Equity	1.46%	$39K	666	US
30	BIOHAVEN LTD	Equity	1.37%	$37K	2,473	VG
31	NOVONESIS A/S	Equity	1.37%	$37K	582	DK
32	PFEPfizer Inc.	Equity	1.34%	$36K	1,494	US
33	VRTXVertex Pharmaceuticals Inc	Equity	1.34%	$36K	72	US
34	NOVARTIS AG	Equity	1.33%	$36K	227	CH
35	UNIQURE NV	Equity	1.23%	$33K	713	NL
36	CPRXCatalyst Pharmaceutical Inc.	Equity	1.07%	$29K	914	US
37	EXELExelixis Inc	Equity	1.04%	$28K	514	US
38	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	1.04%	$28K	1,532	US
39	PTGXProtagonist Therapeutics, Inc	Equity	1.03%	$27K	224	US
40	DYNDyne Therapeutics, Inc. Common Stock	Equity	1.00%	$27K	1,205	US
41	CLDXCelldex Therapeutics, Inc	Equity	0.96%	$26K	694	US
42	EDITEditas Medicine, Inc. Common Stock	Equity	0.95%	$26K	7,881	US
43	ARGXargenx SE American Depositary Shares	Equity	0.94%	$25K	27	NL
44	VKTXViking Therapeutics, Inc	Equity	0.93%	$25K	639	US
45	RGNXREGENXBIO Inc.	Equity	0.93%	$25K	2,079	US
46	CGONCG Oncology, Inc. Common stock	Equity	0.90%	$24K	340	US
47	BNTXBioNTech SE American Depositary Share	Equity	0.88%	$23K	252	DE
48	BIIBBiogen Inc. Common Stock	Equity	0.82%	$22K	102	US
49	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.82%	$22K	10,528	US
50	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	0.77%	$21K	4,942	US
51	DHRDanaher Corporation	Equity	0.75%	$20K	105	US
52	RGENRepligen Corp	Equity	0.72%	$19K	142	US
53	MRKMerck & Co., Inc.	Equity	0.70%	$19K	146	US
54	SANASana Biotechnology, Inc. Common Stock	Equity	0.67%	$18K	5,156	US
55	VERBIO VEREINIGTE BIOENERGIE SE	Equity	0.66%	$18K	520	DE
56	HALOHalozyme Therapeutics, Inc.	Equity	0.65%	$17K	222	US
57	RAREUltragenyx Pharmaceutical Inc.	Equity	0.60%	$16K	479	US
58	SYENSQO SA/NV	Equity	0.59%	$16K	214	BE
59	FMCFMC Corporation	Equity	0.58%	$16K	1,357	US
60	INSMInsmed, Inc.	Equity	0.58%	$16K	146	US
61	GPREGreen Plains, Inc.	Equity	0.58%	$16K	1,010	US
62	ARCTArcturus Therapeutics Holdings Inc. Common Stock	Equity	0.55%	$15K	2,185	US
63	ILMNIllumina Inc	Equity	0.54%	$14K	82	US
64	REGNRegeneron Pharmaceuticals Inc	Equity	0.54%	$14K	23	US
65	NTLAIntellia Therapeutics, Inc	Equity	0.53%	$14K	841	US
66	NUFARM LTD	Equity	0.50%	$13K	7,097	AU
67	TECHBio-Techne Corp.	Equity	0.49%	$13K	185	US
68	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	0.48%	$13K	172	US
69	BMRNBioMarin Pharmaceuticals Inc	Equity	0.44%	$12K	204	US
70	GMABGenmab A/S ADS	Equity	0.42%	$11K	408	DK
71	OXFORD NANOPORE TECHNOLOGIES PLC	Equity	0.40%	$11K	6,496	GB
72	ZTSZOETIS INC.	Equity	0.36%	$10K	135	US
73	GENUS PLC	Equity	0.34%	$9K	320	GB
74	GERNGeron Corp	Equity	0.33%	$9K	6,841	US
75	TSNTyson Foods, Inc.	Equity	0.30%	$8K	138	US
76	RCKTRocket Pharmaceuticals, Inc. Common Stock	Equity	0.30%	$8K	2,310	US
77	ALNYAlnylam Pharmaceuticals, Inc.	Equity	0.29%	$8K	26	US
78	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.28%	$8K	419	US
79	PACBPacific Biosciences of California, Inc.	Equity	0.26%	$7K	4,222	US
80	QIAGEN NV	Equity	0.25%	$7K	172	NL
81	DREYFUS TRSY OBLIG CASH M	Cash	0.11%	$3K	2,870	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	TWSTTWIST BIOSCIENCE CORP	2.32%	5.95%	+41.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	FOLDAmicus Therapeutics Inc.	2.19%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TEMTEMPUS AI INC	0.78%	2.28%	+173.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	Novo Nordisk A/S	1.49%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	LLYELI LILLY & COMPANY	2.64%	4.08%	+41.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	PFEPFIZER INC	2.74%	1.34%	−31.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ACLXArcellx Inc	1.28%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TMOTHERMO FISHER SCIENTIFIC INC	0.26%	1.52%	+581.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BIOHAVEN LTD	0.15%	1.37%	+541.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	BNTXBIONTECH SE	2.09%	0.88%	−52.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	BMYBristol-Myers Squibb Company	1.20%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	Takeda Pharmaceutical Co Ltd.	1.17%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CPRXCATALYST PHARMACEUTICALS INC	—	1.07%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CGEMCULLINAN THERAPEUTICS INC	—	1.04%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	RVMDREVOLUTION MEDICINES INC	0.66%	1.69%	+59.0%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	PTGXPROTAGONIST THERAPEUTICS INC	—	1.03%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	DYNDYNE THERAPEUTICS INC	—	1.00%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CLDXCELLDEX THERAPEUTICS INC	—	0.96%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NTLAINTELLIA THERAPEUTICS INC	1.48%	0.53%	−67.6%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CGONCG ONCOLOGY INC	—	0.90%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ABSIABSCI CORP	0.84%	1.71%	−37.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	AMGNAMGEN INC	2.35%	1.54%	−23.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	GMABGENMAB A/S	1.10%	0.42%	−55.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	DNAGinkgo Bioworks Holdings Inc	0.59%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	REGNREGENERON PHARMACEUTICALS INC	1.13%	0.54%	−29.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	BMRNBIOMARIN PHARMACEUTICAL INC	1.02%	0.44%	−49.8%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	INSMINSMED INC	—	0.58%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	Zealand Pharma As	0.57%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CTVACORTEVA INC	1.45%	1.99%	+62.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BAYER AG	1.01%	1.53%	+47.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NOVONESIS A/S	1.85%	1.37%	−17.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	UNIQURE NV	0.76%	1.23%	−31.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	MRNAMODERNA INC	4.54%	4.14%	−21.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	IMNMIMMUNOME INC	1.86%	2.26%	+49.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	RGNXREGENXBIO INC	1.32%	0.93%	−41.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	VERBIO VEREINIGTE BIOENERGIE SE	1.05%	0.66%	+16.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	FMCFMC CORP	0.20%	0.58%	+413.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	SDGRSchrodinger Inc.	0.38%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CRBUCaribou Biosciences Inc	0.37%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	UTHRUNITED THERAPEUTICS CORP	2.80%	2.45%	+14.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	EXELEXELIXIS INC	0.71%	1.04%	+37.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	RXRXRecursion Pharmaceuticals Inc	0.32%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ARCTARCTURUS THERAPEUTICS HOLDINGS INC	0.85%	0.55%	−11.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DARDARLING INGREDIENTS INC	1.70%	1.94%	+54.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	FATEFate Therapeutics Inc.	0.22%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	NUFARM LTD	0.28%	0.50%	+58.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NTRANATERA INC	2.53%	2.32%	−19.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	GERNGERON CORP	0.53%	0.33%	−13.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BIIBBIOGEN INC	0.74%	0.82%	+13.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	RAREULTRAGENYX PHARMACEUTICAL INC	0.52%	0.60%	−13.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	OXFORD NANOPORE TECHNOLOGIES PLC	0.36%	0.40%	+18.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GPREGREEN PLAINS INC	0.62%	0.58%	+20.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BUNGE GLOBAL SA	1.54%	1.51%	+39.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	TXG10X GENOMICS INC	1.78%	1.81%	−32.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	RCKTROCKET PHARMACEUTICALS INC	0.32%	0.30%	+14.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	QIAGEN NV	0.24%	0.25%	+28.6%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	AstraZeneca PLC	—	2.28%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AZNAstraZeneca PLC	2.15%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	EXASExact Sciences Corp	1.59%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	QIAGEN NV	0.28%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.